ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
87,86
0,40
(0,46%)
Geschlossen 20 Dezember 10:00PM
Echtzeitdaten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
87,86
Gebot
87,84
Fragen
88,02
Volumen
2.783
86,41 Tagesbereich 88,05
57,18 52-Wochen-Bereich 92,77
Marktkapitalisierung
Handelsende
87,46
Handelsbeginn
87,13
Letzte Trade
21
@
88.05
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
5.726
Ausgegebene Aktien
1.246.265.857
Dividendenrendite
3.63%
Kurs-Gewinn-Verhältnis
20,04
Gewinn pro Aktie (EPS)
4,55
Erlöse
27,12B
Nettogewinn
5,67B

Über Gilead Sciences Inc

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Gilead Sciences Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker GIS. The last closing price for Gilead Sciences was 87,46 €. Over the last year, Gilead Sciences shares have traded in a share price range of 57,18 € to 92,77 €.

Gilead Sciences currently has 1.246.265.857 shares in issue. The market capitalisation of Gilead Sciences is 109,00 € billion. Gilead Sciences has a price to earnings ratio (PE ratio) of 20.04.

GIS Neueste Nachrichten

Gilead and Genesis team up on using AI to develop novel therapeutics

Gilead Sciences Inc on Tuesday announced a strategic collaboration with Genesis Therapeutics Inc to discover and deve ...

Gilead notes transfer of Yescarta marketing authorisation from Daiichi

Gilead Sciences Inc on Thursday said that the marketing authorisation in Japan for its chimeric antigen receptor T-ce ...

GLOBAL BUSINESS: Bristol-Myers wins approval for Breyanzi in Japan

The following is a round-up of updates by global companies, issued on Tuesday and not separately reported by Alliance ...

World Health Organisation 'strongly recommends' Pfizer's covid pill

The World Health Organization said Friday it "strongly recommended" Pfizer Inc's covid-19 antiviral pill Paxlovid for ...

TOP NEWS: GSK's ViiV gets USD1.25 billion from Gilead patent pact

GlaxoSmithKline PLC on Wednesday said majority-owned investee ViiV Healthcare has agreed to settle a global patent in ...

Gilead Sciences receives expedited approval for antiviral drug Veklury

Gilead Sciences Inc on Friday said that the US Food & Drug Administration granted its Veklury drug expedited approval ...

Gilead and Merck & Co HIV double drug combo starts Phase 2 study

Gilead Sciences Inc and Merck & Co Inc announced Tuesday the start of a Phase 2 clinical study evaluating an investig ...

Gilead Sciences Teams Up With Vir To Develop Chronic Hepatitis B Cure

Gilead Sciences Inc on Tuesday said it has entered into a clinical collaboration with Vir Biotechnology Inc focused o ...

Gilead Sciences Ups Annual Guidance As Covid-19 Drug Boosts Sales

Gilead Sciences Inc on Monday said it has increased its product sales guidance for 2020 as one of its drugs used to t ...

Gilead's Kite, Oxford BioTherapeutics Partner On Cell Therapy Research

Kite, a Gilead Sciences Inc portfolio company, on Wednesday said it and Oxford BioTherapeutics Ltd have entered into ...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.210.23958927552887.6589.0585.25355587.87577899DE
44.0400014.8198533144883.81999990.4483.51543388.24237322DE
1213.5718.2662538774.2992.7773.3572684.90383663DE
2628.8148.789161727359.0592.7758.17518376.612426DE
5215.321.085997794972.5692.7757.18525672.04280887DE
15624.5638.799368088563.392.7752.06442170.78392236DE
26028.8948.991012379258.9792.7746.1651077065.41504789DE

GIS - Frequently Asked Questions (FAQ)

What is the current Gilead Sciences share price?
The current share price of Gilead Sciences is 87,86 €
How many Gilead Sciences shares are in issue?
Gilead Sciences has 1.246.265.857 shares in issue
What is the market cap of Gilead Sciences?
The market capitalisation of Gilead Sciences is EUR 109B
What is the 1 year trading range for Gilead Sciences share price?
Gilead Sciences has traded in the range of 57,18 € to 92,77 € during the past year
What is the PE ratio of Gilead Sciences?
The price to earnings ratio of Gilead Sciences is 20,04
What is the cash to sales ratio of Gilead Sciences?
The cash to sales ratio of Gilead Sciences is 4,19
What is the reporting currency for Gilead Sciences?
Gilead Sciences reports financial results in USD
What is the latest annual turnover for Gilead Sciences?
The latest annual turnover of Gilead Sciences is USD 27,12B
What is the latest annual profit for Gilead Sciences?
The latest annual profit of Gilead Sciences is USD 5,67B
What is the registered address of Gilead Sciences?
The registered address for Gilead Sciences is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Gilead Sciences website address?
The website address for Gilead Sciences is www.gilead.com
Which industry sector does Gilead Sciences operate in?
Gilead Sciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BDDOrdinary Shares
0,0044 €
(633,33%)
25,87k
M5ZManz Automation Ag Npv
1,75 €
(106,86%)
2,62M
69CCara Therapeutics Inc
0,4656 €
(84,03%)
95,22k
AWY0Percheron Therapeutics Ltd
0,007 €
(75,00%)
758,82k
0PV2Moovly Media Inc
0,0065 €
(62,50%)
500,18k
1RR1Rokmaster Resources Corp
0,006 €
(-50,00%)
4k
D4GDataMetrex AI Ltd
0,003 €
(-46,43%)
406,92k
QNTQuantum Corp
34,80 €
(-40,00%)
26,8k
36GGBM Resources Limited
0,004 €
(-38,46%)
223,04k
N7ENatural Cool Holdings Limited
0,0165 €
(-35,29%)
65k
AXIAtos SE
0,0021 €
(-8,70%)
811,16M
DMLSayona Mining Limited
0,0149 €
(-6,88%)
3,6M
RQ0DWave Quantum Inc
6,228 €
(-27,80%)
3,45M
D7GNel ASA
0,2548 €
(-3,34%)
2,93M
M5ZManz Automation Ag Npv
1,75 €
(106,86%)
2,62M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock